RareCyte, Inc.

📍 Seattle, United States🗓 Founded 2009👥 77 employees💰 Last funded Jan 2024
Biotechnology Research🌐 rarecyte.com
Website LinkedIn
Leaders across Research, Translational Medicine and the Clinic rely on RareCyte as a one-stop resource for Spatial Biology and Liquid Biopsy solutions. Headquartered in Seattle, WA, RareCyte is an innovative precision biology company that has developed technologies and end-to-end integrated platforms enabling advances in oncology, immuno-oncology, maternal-fetal health, and cell and gene therapy. Our highly multiplexed fluorescent imaging systems, reagents and contract services empower investigators to unlock spatial context for key biomarkers and develop therapeutics and companion diagnostics through rare cell analysis.
3
Total investors
1
Early stage
0
Mid stage
0
Late stage
2009
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2011–2024 · investors recorded per year
201112021120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in RareCyte, Inc.?
RareCyte, Inc. has 3 investors on record on gritt.io, including 1 early-stage backers.
When did RareCyte, Inc. last raise funding?
The most recent investment in RareCyte, Inc. recorded on gritt.io was in January 2024.
When was RareCyte, Inc. founded?
RareCyte, Inc. was founded in 2009.
What industry is RareCyte, Inc. in?
RareCyte, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is RareCyte, Inc. based?
RareCyte, Inc. is headquartered in Seattle, United States.